December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Rajat Thawani on “Combination Immunotherapy clinical trials in NSCLC”
Sep 19, 2024, 18:47

Rajat Thawani on “Combination Immunotherapy clinical trials in NSCLC”

Rajat Thawani, Assistant Professor, University of Chicago Hematology/Oncology, shared a post on X:

It was an honor to present a talk on “Combination Immunotherapy clinical trials in NSCLC” at the Ontario Institute for Cancer Research for OICR Mondays.

In summary, I believe a good second line NSCLC option would be able to compete with anti PD-1/PD-L1 options.

Image

Otherwise, we will be combining drugs to anti PD-1 agents (+/- chemotherapy) to improve ORR. We will have many options to choose from — dual checkpoints, ADCs, vaccines, cytokines and targeted therapies! How do we choose the best partner for the patient — Use AI for ‘precision immunotherapy?”

Image

Radiological artificial intelligence – predicting personalized immunotherapy outcomes in lung cancer

Authors: Laila C. Roisman, Waleed Kian, Alaa Anoze, Vered Fuchs, Maria Spector, Roee Steiner, Levi Kassel, Gilad Rechnitzer, Iris Fried, Nir Peled and Naama R. Bogot.

Rajat Thawani on "Combination Immunotherapy clinical trials in NSCLC"

Source: Rajat Thawani/X